کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
3346045 | 1215766 | 2011 | 5 صفحه PDF | دانلود رایگان |

The herpesvirus entry mediator (HVEM; TNFRSF14) can activate either proinflammatory or inhibitory signaling pathways. HVEM engages two distinct types of ligands, the canonical TNF-related cytokines, LIGHT and Lymphotoxin-α, and the Ig-related membrane proteins, BTLA (B and T lymphocyte attenuator) and CD160. Recent evidence indicates that the signal generated by HVEM depends on the context of its ligands expressed in trans or in cis. HVEM engagement by all of its ligands in trans initiates bidirectional signaling. In contrast, naïve T cells coexpress BTLA and HVEM forming a cis-complex that interferes with the activation of HVEM by extraneous ligands in the surrounding microenvironment. The HVEM Network is emerging as a key survival system for effector and memory T cells in mucosal tissues.
► HVEM has five distinct ligands: LIGHT and LTα in the TNF family and BTLA, CD160 and herpesvirus gD in the Ig family.
► HVEM-BTLA forms a bidirectional signaling pathway in trans.
► Naïve T cells coexpress HVEM and BTLA forming an inhibitory complex in cis interfering with extraneous ligands in the microenvironment.
► The HVEM Network is critical for the survival of memory CD4 T cells in persistent mucosal inflammation.
Journal: Current Opinion in Immunology - Volume 23, Issue 5, October 2011, Pages 627–631